High Fibroblast Growth Factor 23 as a Biomarker for Severe Cardiac Impairment in Children with Chronic Kidney Disease: A Single Tertiary Center Study

INTRODUCTION: Left ventricular hypertrophy (LVH) is the most common cardiac abnormality in chronic kidney disease (CKD). Changes in cardiac geometry and functions may occur in an early stage and worsen as CKD progresses. Recently, the role of fibroblast growth factor 23 (FGF23) is being highlighted...

Descripción completa

Detalles Bibliográficos
Autores principales: Palupi-Baroto, Retno, Hermawan, Kristia, Murni, Indah Kartika, Nurlitasari, Tiara, Prihastuti, Yuli, Sekali, Debora Roselita Karo, Ambarsari, Cahyani Gita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197584/
https://www.ncbi.nlm.nih.gov/pubmed/34135617
http://dx.doi.org/10.2147/IJNRD.S304143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197584/
https://www.ncbi.nlm.nih.gov/pubmed/34135617
http://dx.doi.org/10.2147/IJNRD.S304143

Ejemplares similares